Eamon Drugs Private Limited, a active private limited company, was established on 04 September 1985 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24114MP1985PTC003021. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.24 M.
Formerly known as Shyra Chemicals Private Limited, Midway Drugs Private Limited. It upholds a compliant status. Employing 18 professional, Its leadership includes Mahendra Kumar Mandloi (Director), Rishabh Mandloi (Director), Udit Sodani (Director). Past directors included Ayush Kabra, Harish Gangwani, Rishabh Mandloi. It holds ₹2.20 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 104-A-2 105 A-1 Sect E Sanwer Road, Indore, Madhya Pradesh, 452001.
U24114MP1985PTC003021
003021
04 September 1985
₹1.00 Cr
₹7.24 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Eamon Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahendra Kumar Mandloi | Director | 25 Jan 2018 | Current |
| Rishabh Mandloi | Director | 14 Jul 2020 | Current |
| Udit Sodani | Director | 25 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jan 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Jan 2018 | Past |
| Pramod Abcsdd | Director | 27 Dec 2020 | Past |
| Pramod Abcsdd | Director | 16 May 2023 | Past |
| Pramod Abcsdd | Additional Director | 25 Jan 2018 | Past |
| Pramod Abcsdd | Additional Director | 25 Jan 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eamon Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.39% increase. The company also saw a substantial improvement in profitability, with a 31.87% increase in profit. The company's net worth Soared by an impressive increase of 15.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Eamon Drugs had a promoter holding of 76.00% and a public holding of 24.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Oct 2024 | Others | ₹2.00 M | Open |
| 07 Mar 2023 | Others | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Eamon Drugs has a workforce of 18 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eamon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eamon Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Eamon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Eamon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was recorded as a recent event.
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100995985 was registered on 11 Oct 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 100685182 was registered on 07 Mar 2023. was recorded as a recent event.
Rishabh Mandloi was appointed as a Director was appointed as a Director on 14 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
Progress on Mahendra Kumar Mandloi was appointed as a Director was appointed as a Director on 25 Jan 2018 & has been associated with this company since 7 years 10 months . was documented.
The CIN of Eamon Drugs Private Limited is U24114MP1985PTC003021.
Eamon Drugs Private Limited is headquartered at 104-A-2 105 A-1 Sect E Sanwer Road, Indore, Madhya Pradesh, 452001.
Eamon Drugs Private Limited was incorporated on 04 September 1985.
The current directors of Eamon Drugs Private Limited are
The primary industry of Eamon Drugs Private Limited is Manufacturing.
Eamon Drugs Private Limited is unlisted.
The authorized capital of Eamon Drugs Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.24 M.
The compliance status of Eamon Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX